|
1
|
Sales R and Torres T: Psoriasis and
metabolic syndrome. Acta Dermatovenerol Croat. 22:169–174.
2014.PubMed/NCBI
|
|
2
|
Diani M, Altomare G and Reali E: T cell
responses in psoriasis and psoriatic arthritis. Autoimmun Rev.
14:286–292. 2015. View Article : Google Scholar
|
|
3
|
Leipe J, Grunke M, Dechant C, Reindl C,
Kerzendorf U, Schulze-Koops H and Skapenko A: Role of Th17 cells in
human autoimmune arthritis. Arthritis Rheum. 62:2876–2885. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boniface K, Guignouard E, Pedretti N,
Garcia M, Delwail A, Bernard FX, Nau F, Guillet G, Dagregorio G,
Yssel H, et al: A role for T cell-derived interleukin 22 in
psoriatic skin inflammation. Clin Exp Immunol. 150:407–415. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nograles KE, Zaba LC, Shemer A,
Fuentes-Duculan J, Cardinale I, Kikuchi T, Ramon M, Bergman R,
Krueger JG and Guttman-Yassky E: IL-22-producing ῾T22᾽ T cells
account for upregulated IL-22 in atopic dermatitis despite reduced
IL-17-producing TH17 T cells. J Allergy Clin Immunol.
123:1244–1252.e2. 2009. View Article : Google Scholar
|
|
6
|
Cauli A and Mathieu A: Psoriatic
arthritis: Genetics and pathogenesis. Reumatismo. 64:71–78. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Benham H, Norris P, Goodall J, Wechalekar
MD, FitzGerald O, Szentpetery A, Smith M, Thomas R and Gaston H:
Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis
Res Ther. 15:R1362013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang H, Jin X, Li Y, Jiang H, Tang X, Yang
X, Cheng H, Qiu Y, Chen G, Mei J, et al: A large-scale screen for
coding variants predisposing to psoriasis. Nat Genet. 46:45–50.
2014. View
Article : Google Scholar
|
|
9
|
Garber K: Genetics: Deep exploration.
Nature. 492(Suppl): S56–S57. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsoi LC, Spain SL, Knight J, Ellinghaus E,
Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, et al:
Identification of 15 new psoriasis susceptibility loci highlights
the role of innate immunity. Nat Genet. 44:1341–1348. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Apel M, Uebe S, Bowes J, Giardina E,
Korendowych E, Juneblad K, Pasutto F, Ekici AB, McManus R, Ho P, et
al: Variants in RUNX3 contribute to susceptibility to psoriatic
arthritis, exhibiting further common ground with ankylosing
spondylitis. Arthritis Rheum. 65:1224–1231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen HX, Wang S, Wang Z, Zhang ZP and Shi
SS: Overexpression of RUNX3 inhibits malignant behaviour of Eca109
cells in vitro and vivo. Asian Pac J Cancer Prev. 15:1531–1537.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yagi R, Junttila IS, Wei G, Urban JF Jr,
Zhao K, Paul WE and Zhu J: The transcription factor GATA3 actively
represses RUNX3 protein-regulated production of interferon-gamma.
Immunity. 32:507–517. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Blyth K, Cameron ER and Neil JC: The RUNX
genes: Gain or loss of function in cancer. Nat Rev Cancer.
5:376–387. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
He SY, Jiang RF, Jiang J, Xiang YS and
Wang L: Investigation of methylation and protein expression of the
gene in colon carcinogenesis. Biomed Rep. 3:687–690.
2015.PubMed/NCBI
|
|
16
|
Ito K, Lim AC, Salto-Tellez M, Motoda L,
Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, et al: RUNX3
attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
Cancer Cell. 14:226–237. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brenner O, Levanon D, Negreanu V, Golubkov
O, Fainaru O, Woolf E and Groner Y: Loss of Runx3 function in
leukocytes is associated with spontaneously developed colitis and
gastric mucosal hyperplasia. Proc Natl Acad Sci USA.
101:16016–16021. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fainaru O, Woolf E, Lotem J, Yarmus M,
Brenner O, Goldenberg D, Negreanu V, Bernstein Y, Levanon D, Jung S
and Groner Y: Runx3 regulates mouse TGF-beta-mediated dendritic
cell function and its absence results in airway inflammation. EMBO
J. 23:969–979. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naoe Y, Setoguchi R, Akiyama K, Muroi S,
Kuroda M, Hatam F, Littman DR and Taniuchi I: Repression of
interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to
the Il4 silencer. J Exp Med. 204:1749–1755. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Djuretic IM, Cruz-Guilloty F and Rao A:
Regulation of gene expression in peripheral T cells by Runx
transcription factors. Adv Immunol. 104:1–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oji V and Luger TA: The skin in psoriasis:
Assessment and challenges. Clin Exp Rheumatol. 93(Suppl 5): S14–19.
2015.
|
|
22
|
Wang G, Wang L, Sun S, Wu J and Wang Q:
Quantitative measurement of serum microRNA-21 expression in
relation to breast cancer metastasis in Chinese females. Ann Lab
Med. 35:226–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ghoreschi K, Weigert C and Röcken M:
Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol.
25:574–580. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lonnberg AS, Skov L, Skytthe A, Kyvik KO,
Pedersen OB and Thomsen SF: Heritability of psoriasis in a large
twin sample. Br J Dermatol. 169:412–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou L, Chong MM and Littman DR:
Plasticity of CD4+ T cell lineage differentiation. Immunity.
30:646–655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miossec P: IL-17 and Th17 cells in human
inflammatory diseases. Microbes Infect. 11:625–630. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van den Berg WB and McInnes IB: Th17 cells
and IL-17 a-focus on immunopathogenesis and immunotherapeutics.
Semin Arthritis Rheum. 43:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bettelli E, Korn T, Oukka M and Kuchroo
VK: Induction and effector functions of T(H)17 cells. Nature.
453:1051–1057. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peck A and Mellins ED: Breaking old
paradigms: Th17 cells in autoimmune arthritis. Clin Immunol.
132:295–304. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Volpe E, Battistini L and Borsellino G:
Advances in T helper 17 cell biology: Pathogenic role and potential
therapy in multiple sclerosis. Mediators Inflamm. 2015:4751582015.
View Article : Google Scholar
|
|
31
|
Asarch A, Barak O, Loo DS and Gottlieb AB:
Th17 cells: A new paradigm for cutaneous inflammation. J Dermatolog
Treat. 19:259–266. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Duhen T, Geiger R, Jarrossay D,
Lanzavecchia A and Sallusto F: Production of interleukin 22 but not
interleukin 17 by a subset of human skin-homing memory T cells. Nat
Immunol. 10:857–863. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Y, Yang B, Zhou M, Li L, Zhou H, Zhang
J, Chen H and Wu C: Memory IL-22-producing CD4+ T cells specific
for Candida albicans are present in humans. Eur J Immunol.
39:1472–1479. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
N, Pan HF and Ye DQ: Th22 in inflammatory
and autoimmune disease: Prospects for therapeutic intervention. Mol
Cell Biochem. 353:41–46. 2011. View Article : Google Scholar
|
|
35
|
Kaur S, Zilmer K, Leping V and Zilmer M:
Comparative study of systemic inflammatory responses in psoriasis
vulgaris and mild to moderate allergic contact dermatitis.
Dermatology. 225:54–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chandran V: Soluble biomarkers may
differentiate psoriasis from psoriatic arthritis. J Rheumatol
Suppl. 89:65–66. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sabat R and Wolk K: Research in practice:
IL-22 and IL-20: Significance for epithelial homeostasis and
psoriasis pathogenesis. J Dtsch Dermatol Ges. 9:518–523.
2011.English, German. PubMed/NCBI
|
|
38
|
Wolk K, Haugen HS, Xu W, Witte E, Waggie
K, Anderson M, Vom Baur E, Witte K, Warszawska K, Philipp S, et al:
IL-22 and IL-20 are key mediators of the epidermal alterations in
psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl).
87:523–536. 2009. View Article : Google Scholar
|
|
39
|
Wolk K, Witte E, Warszawska K,
Schulze-Tanzil G, Witte K, Philipp S, Kunz S, Döcke WD, Asadullah
K, Volk HD, et al: The Th17 cytokine IL-22 induces IL-20 production
in keratinocytes: A novel immunological cascade with potential
relevance in psoriasis. Eur J Immunol. 39:3570–3581. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liang Y, Pan HF and Ye DQ: Therapeutic
potential of STAT4 in autoimmunity. Expert Opin Ther Targets.
18:945–960. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Subramaniam MM, Chan JY, Yeoh KG, Quek T,
Ito K and Salto-Tellez M: Molecular pathology of RUNX3 in human
carcinogenesis. Biochim Biophys Acta. 1796:315–331. 2009.PubMed/NCBI
|
